R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

Rare Disease Day: Enhancing clinical trial success in rare d...

Rare diseases impact an estimated 300 million people globally, while around one in five cancers are considered a rare disease.

R&D

Looking to the future of clinical trials: Gene therapy, prec...

Next-generation technologies in medicine have significantly expanded our ability to identify and address rare diseases, propelling forwards the development of more effective and targeted tr

R&D

Accelerating the process, transforming therapies and advanci...

Next-generation technology is enabling drug discovery at an entirely new scale, accelerating the process, transforming therapies and advancing precision medicine, and resulting in better pa

R&D

The opportunities and challenges facing rare disease therapi...

To mark upcoming Rare Disease Day, pharmaphorum asked a panel of experts to give their thoughts on the opportunities and challenges facing developers of rare disease therapies in 2024.

R&D

diagnostics device for multiple conditions

In search of the fabled tricorder

When two or more people from the world of medical technology meet, talk inevitably turns to the ongoing, yet elusive, search for an industry-standard, multi-disciplinary diagnostic device –

R&D

This week in clinical trials: 29th January to 2nd February

Continuing our weekly clinical trial round-ups, here we look at developments in life sciences research and development announced during the week of 29th January to 2nd